Claes Mörlin - Concepedia

Author

Claes Mörlin

Also Known As

C Morlin, C Mörlin, C. MÖRLIN, C. Mörlin, C. Mørlin, CLAES MÖRLIN, Claes Morlin, Claes Mörlin, Cristiane Bisognin Morlin, Åsa Kettis-Lindblad

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Uppsala University Hospital Uppsala University Lund University Karolinska University Hospital Stockholm South General Hospital

About

Claes Mörlin is an author at Uppsala University Hospital specializing in medicine, hypertension, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	2.3K
2	Business	1	1	20
3	Nursing	1	1	49
4	Public Health	1	1	20
5	Health Informatics	1	1	20

Claes Mörlin

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial Lennart Hansson, Lars Lindholm, Leo Niskanen, The Lancet HypertensionCardiovascular DiseaseAntihypertensive AgentsMedicineAntihypertensive Therapy	1999	2K
A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Ulrika Gillespie, Anna Alassaad, Dan Henrohn, PubMed	2009	572
Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups Thomas Pollare, Hans Lithell, Claes Mörlin, Journal of Hypertension	1989	180
The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events F Mindlen, Roberto Nordaby, M I Soto Ruiz, Queensland's institutional digital repository (The University of Queensland) Non-pharmacological InterventionPreventive MedicineCardiovascular DiseaseAntihypertensive TherapyClinical Trials	1996	154
Effects of Pharmacists' Interventions on Appropriateness of Prescribing and Evaluation of the Instruments' (MAI, STOPP and STARTs') Ability to Predict Hospitalization–Analyses from a Randomized Controlled Trial Ulrika Gillespie, Anna Alassaad, Margareta Hammarlund‐Udenaes, PLoS ONE	2013	124
Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man Claes Mörlin, B. Gunnar Wallin, Britt Marie Eriksson Acta Physiologica Scandinavica	1983	84
Muscle sympathetic activity and venous plasma noradrenaline concentrations during static exercise in normotensive and hypertensive subjects B. Gunnar Wallin, Claes Mörlin, Paul Hjemdahl Acta Physiologica Scandinavica	1987	76
Perceived value of ward-based pharmacists from the perspective of physicians and nurses Ulrika Gillespie, Claes Mörlin, Margareta Hammarlund‐Udenaes, International Journal of Clinical Pharmacy NursingHealthcare ValuePerceived ValueClinical PharmacyPharmaceutical Care	2012	49
Comparative Trial of Lisinopril and Nifedipine in Mild to Severe Essential Hypertension Claes Mörlin, H Baglivo, J. K. Boeijinga, Journal of Cardiovascular Pharmacology	1987	43
Relation Between Low Dose of Hydrochlorothiazide, Antihypertensive Effect and Adverse Effects A. J. Jounela, Mauno Lilja, Jarmo Lumme, Blood Pressure	1994	33

Page 1